SynergyFinder: a web application for analyzing drug combination dose-response matrix data

Aleksandr Ianevski1, Liye He1, Tero Aittokallio1,2

  • 1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00290 Helsinki, Finland.

Abstract

Insights

A new web application, SynergyFinder, aids in analyzing cancer drug combinations. It helps researchers evaluate drug synergy and resistance, improving cancer treatment strategies.

Area of Science:

  • Oncology
  • Bioinformatics
  • Pharmacology

Background:

  • Drug resistance and sensitivity pose significant challenges in cancer treatment.
  • Rational drug combination design is a key strategy to overcome these issues.
  • Pre-clinical evaluation of pairwise drug combinations is crucial for therapeutic development.

Purpose of the Study:

  • To develop a user-friendly web application for analyzing drug combination effects.
  • To facilitate the systematic evaluation of pairwise drug combinations in cancer research.
  • To provide flexible synergy scoring models and interactive visualization tools.

Main Methods:

  • Implementation of the SynergyFinder R-package into a web application.
  • Integration of multiple synergy scoring models for comprehensive analysis.
  • Development of an interactive interface for visualizing drug combination landscapes.

Main Results:

  • The SynergyFinder web application offers a flexible platform for analyzing drug combination data.
  • It enables interactive visualization of drug synergy and combination effects.
  • The tool supports multiple synergy scoring models for robust pre-clinical evaluation.

Conclusions:

  • The SynergyFinder web application streamlines the analysis of drug combination experiments.
  • It enhances the systematic evaluation of pre-clinical drug combinations for cancer therapy.
  • This tool supports rational drug design to combat cancer drug resistance and sensitivity.

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...